<DOC>
	<DOCNO>NCT02022527</DOCNO>
	<brief_summary>The combined Antiplatelet Anticoagulant treatment decrease thrombus formation overall mortality . Also initiation efficacious early anticoagulation protocol important potential impact rate early thromboembolic complication mechanical valve implantation . An important question remain answered whether combination would cost effective Warfarin alone , reduction major bleeding . In addition , knowledge cost-effectiveness yet establish Egypt . The aim trial base economic evaluation conduct cost-effectiveness analysis combination low-dose Aspirin Warfarin versus Warfarin alone prosthetic valve patient medical provider perspective specially misconception still exist physician Egypt cost complication worthy main aim test cost complication .</brief_summary>
	<brief_title>Cost Effectiveness Analysis In Patients With Heart Valve Prosthesis</brief_title>
	<detailed_description>The measurement assess : A- Number patient improve follow : 1 . Demographic data 2 . Diagnosis 3 . Laboratory test ( CBC , Prothrombin Time , liver renal function test ) 4 . Echocardiography profile B-Costs : Direct medical cost assess directly hospital 's record tender list .</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Salicylates</mesh_term>
	<mesh_term>Salicylic Acid</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Patients operate Ain Shams University Hospitals aortic and/ mitral valve replacement . Congenital blood disorder , Hemophilia . Advanced liver disease Advanced renal disease ( dialysis patient ) Aspirin sensitivity Autoimmune diseases Biological bioprosthesis valve Noncompliant &amp; Drop patient Pregnant woman Caucasians .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Cost-Effectiveness ,</keyword>
	<keyword>Heart valve prosthesis</keyword>
	<keyword>Warfarin ,</keyword>
	<keyword>Aspirin ,</keyword>
	<keyword>Egypt</keyword>
</DOC>